Notice: This company has been marked as potentially delisted and may not be actively trading. Histogenics (HSGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends HSGX vs. SMTI, INGN, LAKE, ZJYL, SPAI, APT, RBOT, MLSS, NTRB, and CLGNShould you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Safe Pro Group Inc. Common Stock (SPAI), Alpha Pro Tech (APT), Vicarious Surgical (RBOT), Milestone Scientific (MLSS), Nutriband (NTRB), and CollPlant Biotechnologies (CLGN). Histogenics vs. Sanara MedTech Inogen Lakeland Industries Jin Medical International Safe Pro Group Inc. Common Stock Alpha Pro Tech Vicarious Surgical Milestone Scientific Nutriband CollPlant Biotechnologies Sanara MedTech (NASDAQ:SMTI) and Histogenics (NASDAQ:HSGX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, community ranking, media sentiment, valuation and institutional ownership. Does the MarketBeat Community believe in SMTI or HSGX? Histogenics received 341 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 71.66% of users gave Histogenics an outperform vote while only 54.55% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes1854.55% Underperform Votes1545.45% HistogenicsOutperform Votes35971.66% Underperform Votes14228.34% Do analysts prefer SMTI or HSGX? Sanara MedTech presently has a consensus target price of $44.00, suggesting a potential upside of 17.84%. Given Sanara MedTech's stronger consensus rating and higher probable upside, equities analysts clearly believe Sanara MedTech is more favorable than Histogenics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Histogenics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer SMTI or HSGX? In the previous week, Sanara MedTech had 3 more articles in the media than Histogenics. MarketBeat recorded 3 mentions for Sanara MedTech and 0 mentions for Histogenics. Sanara MedTech's average media sentiment score of 0.63 beat Histogenics' score of 0.00 indicating that Sanara MedTech is being referred to more favorably in the media. Company Overall Sentiment Sanara MedTech Positive Histogenics Neutral Is SMTI or HSGX more profitable? Histogenics has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.71%. Sanara MedTech's return on equity of -19.86% beat Histogenics' return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% Histogenics N/A -34.96%18.40% Which has more risk & volatility, SMTI or HSGX? Sanara MedTech has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, Histogenics has a beta of 3.1, suggesting that its stock price is 210% more volatile than the S&P 500. Do institutionals & insiders have more ownership in SMTI or HSGX? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 40.4% of Histogenics shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by company insiders. Comparatively, 19.7% of Histogenics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has stronger earnings and valuation, SMTI or HSGX? Sanara MedTech has higher revenue and earnings than Histogenics. Sanara MedTech is trading at a lower price-to-earnings ratio than Histogenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$64.99M5.02-$4.30M-$0.99-37.72HistogenicsN/AN/A-$8.64M-$0.79-1.16 SummarySanara MedTech beats Histogenics on 9 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSGX vs. The Competition Export to ExcelMetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$86.89M$9.83B$5.10B$8.84BDividend YieldN/A1.10%5.04%4.07%P/E Ratio-1.1617.8895.1214.22Price / SalesN/A30.601,217.3088.42Price / CashN/A23.2339.4936.27Price / Book-91.854.836.976.37Net Income-$8.64M$182.72M$118.73M$225.56M Histogenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSGXHistogenicsN/A$0.92+4.6%N/A+113.1%$86.89MN/A-1.1649SMTISanara MedTech1.2304 of 5 stars$37.34+0.2%$44.00+17.8%+17.2%$326.35M$64.99M0.0060INGNInogen3.0472 of 5 stars$9.24-2.3%$7.00-24.2%+63.4%$220.10M$315.66M-4.20834LAKELakeland Industries4.4003 of 5 stars$22.10+4.5%$26.50+19.9%+44.7%$163.54M$124.69M88.081,750News CoverageZJYLJin Medical InternationalN/A$1.01+0.0%N/A-94.1%$156.57M$19.82M0.00245Positive NewsSPAISafe Pro Group Inc. Common StockN/A$4.58+43.1%N/AN/A$63.02MN/A0.0011News CoverageGap UpTrading HaltedHigh Trading VolumeAPTAlpha Pro TechN/A$5.31+1.3%N/A+11.1%$58.41M$61.23M14.46120RBOTVicarious Surgical2.0705 of 5 stars$9.56+5.9%$10.25+7.2%-26.1%$56.40MN/A-0.973News CoverageMLSSMilestone Scientific2.1893 of 5 stars$0.70+3.2%$1.25+78.6%-15.8%$54.52M$9.83M0.0030Analyst ForecastGap UpNTRBNutriband0.6322 of 5 stars$4.80-3.6%N/A+125.3%$53.33M$2.09M0.0010CLGNCollPlant Biotechnologies1.8792 of 5 stars$4.18-1.2%$11.00+163.2%-24.2%$47.86M$10.96M0.0070Upcoming Earnings Related Companies and Tools Related Companies SMTI Competitors INGN Competitors LAKE Competitors ZJYL Competitors SPAI Competitors APT Competitors RBOT Competitors MLSS Competitors NTRB Competitors CLGN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSGX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
